These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 6817443)
1. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex. Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443 [TBL] [Abstract][Full Text] [Related]
2. [Factor VIII complex activities in acute leukemia]. Pniejnia-Olszyński W; Lopaciuk S Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320 [TBL] [Abstract][Full Text] [Related]
3. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease. Chediak J; Peake I; Bloom A Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844 [TBL] [Abstract][Full Text] [Related]
4. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193 [TBL] [Abstract][Full Text] [Related]
5. A critical evaluation of the available methods for the determination of factor VIII von Willebrand. Casonato A; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633 [TBL] [Abstract][Full Text] [Related]
6. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of von Willebrand's disease: study of 40 Iranian cases. Shoa'i I; Lavergne JM; Ardaillou N; Obert B; Ala F; Meyer D Br J Haematol; 1977 Sep; 37(1):67-83. PubMed ID: 303911 [TBL] [Abstract][Full Text] [Related]
8. Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC). Tran TH; Lämmle B; Duckert F Am J Clin Pathol; 1984 Nov; 82(5):565-72. PubMed ID: 6437209 [TBL] [Abstract][Full Text] [Related]
9. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag. Tran TH; Duckert F Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848 [TBL] [Abstract][Full Text] [Related]
10. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate. Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090 [TBL] [Abstract][Full Text] [Related]
11. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation]. Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063 [TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120). Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753 [TBL] [Abstract][Full Text] [Related]
13. Factor VIII: C and factor VIII R: Ag in Argentine hemorrhagic fever. Molinas FC; Maiztegui JI Thromb Haemost; 1981 Aug; 46(2):525-7. PubMed ID: 6795740 [TBL] [Abstract][Full Text] [Related]
14. [Acquired hemophilia A due to factor VIIIC inhibitor: detection of circulating immune complexes containing factor VIIIC but not factor VIIIR]. Pfyffer M; Kistler HJ; von Felten A Schweiz Med Wochenschr; 1983 Oct; 113(40):1456-9. PubMed ID: 6417777 [TBL] [Abstract][Full Text] [Related]
15. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C). Ballard JO; Sanders JC; Eyster ME Thromb Haemost; 1981 Feb; 45(1):68-72. PubMed ID: 6166064 [TBL] [Abstract][Full Text] [Related]
16. [Determination of the factor VIII ristocetin cofactor (Willebrand factor) using a semi-quantitative slide test. Preliminary results]. Bogaty-Yver J; Musitelli JJ; Conard J; Horellou MH; Samama M Ann Biol Clin (Paris); 1983; 41(5):319-24. PubMed ID: 6421207 [TBL] [Abstract][Full Text] [Related]
17. Acquired factor VIII inhibitor. Simpson WG; Neefe J; Zang J; Drosick R; Kearns R J Ky Med Assoc; 1991 Nov; 89(11):555-7. PubMed ID: 1748831 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease. Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740 [TBL] [Abstract][Full Text] [Related]
19. Acquired haemophilia: functional study of antibodies to Factor VIII. Allain JP; Gaillandre A; Frommel D Thromb Haemost; 1981 Jun; 45(3):285-9. PubMed ID: 6792741 [TBL] [Abstract][Full Text] [Related]
20. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies. Tran TH; Marbet GA; Duckert F Thromb Haemost; 1981 Dec; 46(4):699-705. PubMed ID: 6800051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]